Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Phase 3 × Cognitive Dysfunction × mazdutide × Clear all

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Conditions

Lymphoma, Follicular 1 Diabetes Mellitus, Type 2 1 Dementia 1 Cognitive Dysfunction 1

Interventions

mazdutide 1 Tablets 1 Sugars 1 Standard of Care 1 Sodium Chloride 1 Radiotherapy, Intensity-Modulated 1 Metformin 1 Memantine 1 Hormones 1 G(M1) Ganglioside 1 Exercise 1 Donepezil 1 Counseling 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT07083154 2026-03-05

GLP-1/GCG Dual Agonist in Type 2 Diabetes With Early Dementia (LIGHT-COG Study)

The Affiliated Nanjing Drum Tower Hospital of Nanjing University Medical School

Phase 3 Recruiting

Dementia, Diabetes Mellitus, Type 2, Lymphoma, Follicular, Cognitive Dysfunction

Data powered by HemOnc (CC BY 4.0) Colophon ⚡